The results showed that this treatment regimen dramatically reduced the tumor metastasis in mouse lungs compared with anti-PD-1 + anti-CTLA-4 Abs and PBS treatment (Fig. 5b, c and Supplementary Fig. 22a, b). The gene discussed is CTLA4; the disease is neoplasm.